Provided by Tiger Fintech (Singapore) Pte. Ltd.

CVRx, Inc.

6.48
-0.7900-10.87%
Post-market: 6.910.4301+6.64%19:39 EDT
Volume:450.05K
Turnover:3.01M
Market Cap:168.71M
PE:-2.44
High:7.19
Open:7.15
Low:6.43
Close:7.27
Loading ...

Company Profile

Company Name:
CVRx, Inc.
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
206
Office Location:
9201 West Broadway Avenue,Suite 650,Minneapolis,Minnesota,United States
Zip Code:
55445
Fax:
763 416 2841
Introduction:
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Directors

Name
Position
Nadim Yared
President and Chief Executive Officer,Director
John M. Nehra
Independent Lead Director
Ali Behbahani
Director
Geoff Pardo
Director
Joseph Slattery
Director
Kirk Nielsen
Director
Mudit K. Jain
Director

Shareholders

Name
Position
Nadim Yared
President and Chief Executive Officer,Director
Jared Oasheim
Chief Financial Officer
Dean Bruhn Ding
Vice President of Regulatory Affairs and Quality Assurance
John Brintnall
Chief Strategy Officer and Secretary
Liz Galle
Vice President of Global Clinical Research
Paul Verrastro
Chief Marketing Officer